FR2405926A1 - (asn2)-thymosine a1 et procede de preparation - Google Patents

(asn2)-thymosine a1 et procede de preparation

Info

Publication number
FR2405926A1
FR2405926A1 FR7835404A FR7835404A FR2405926A1 FR 2405926 A1 FR2405926 A1 FR 2405926A1 FR 7835404 A FR7835404 A FR 7835404A FR 7835404 A FR7835404 A FR 7835404A FR 2405926 A1 FR2405926 A1 FR 2405926A1
Authority
FR
France
Prior art keywords
thymosin
asn2
preparation
immunostimulator
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7835404A
Other languages
English (en)
Other versions
FR2405926B1 (fr
Inventor
Su-Sun Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/871,563 external-priority patent/US4116951A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2405926A1 publication Critical patent/FR2405926A1/fr
Application granted granted Critical
Publication of FR2405926B1 publication Critical patent/FR2405926B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne un composé chimique nouveau. Il s'agit de l'(Asn**2)-thymosine alpha 1 et ses sels pharmaceutiquement acceptables. Ce peptide est utile comme immunostimulateur.
FR7835404A 1977-04-22 1978-12-15 (asn2)-thymosine a1 et procede de preparation Granted FR2405926A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78989877A 1977-04-22 1977-04-22
US05/871,563 US4116951A (en) 1977-04-22 1978-01-23 [Asn2 ]-thymosin α1 and analogs thereof

Publications (2)

Publication Number Publication Date
FR2405926A1 true FR2405926A1 (fr) 1979-05-11
FR2405926B1 FR2405926B1 (fr) 1983-09-09

Family

ID=27120967

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7811686A Granted FR2401134A1 (fr) 1977-04-22 1978-04-20 Procede pour la preparation de thymosine a1 et d'un analogue
FR7835404A Granted FR2405926A1 (fr) 1977-04-22 1978-12-15 (asn2)-thymosine a1 et procede de preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7811686A Granted FR2401134A1 (fr) 1977-04-22 1978-04-20 Procede pour la preparation de thymosine a1 et d'un analogue

Country Status (18)

Country Link
JP (1) JPS53137914A (fr)
AT (1) AT364470B (fr)
CA (1) CA1113088A (fr)
CH (3) CH641152A5 (fr)
DE (1) DE2817082A1 (fr)
DK (1) DK147918C (fr)
ES (1) ES469016A1 (fr)
FI (1) FI781241A (fr)
FR (2) FR2401134A1 (fr)
GB (1) GB1590668A (fr)
GR (1) GR71886B (fr)
HU (1) HU180783B (fr)
IT (1) IT1113134B (fr)
LU (1) LU79488A1 (fr)
NL (1) NL7804364A (fr)
NO (2) NO781404L (fr)
PT (1) PT67937B (fr)
SE (1) SE447262B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
EP0033384B1 (fr) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Médicaments contenant des fragments de thymosine-alpha-1, leur activité immunostimulante, et fragments de thymosine-alpha-1
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
EP0056594B1 (fr) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Fragments de thymosine alpha-1 et compositions pharmaceutiques à action immunorégulatrice qui les contiennent
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α－1衍生物
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1

Also Published As

Publication number Publication date
IT1113134B (it) 1986-01-20
CH641152A5 (en) 1984-02-15
LU79488A1 (de) 1979-05-25
CH640218A5 (en) 1983-12-30
PT67937A (en) 1978-05-01
CH641153A5 (en) 1984-02-15
ATA286178A (de) 1981-03-15
NL7804364A (nl) 1978-10-24
NO148924B (no) 1983-10-03
AT364470B (de) 1981-10-27
HU180783B (en) 1983-04-29
FR2405926B1 (fr) 1983-09-09
SE7804612L (sv) 1978-12-20
FR2401134A1 (fr) 1979-03-23
ES469016A1 (es) 1980-01-01
DE2817082A1 (de) 1978-11-02
DK147918B (da) 1985-01-07
NO821608L (no) 1978-10-24
PT67937B (en) 1980-04-07
FI781241A (fi) 1978-10-23
JPS53137914A (en) 1978-12-01
SE447262B (sv) 1986-11-03
FR2401134B1 (fr) 1983-09-30
NO148924C (no) 1984-01-11
DK169478A (da) 1978-10-23
GR71886B (fr) 1983-08-04
NO781404L (no) 1978-10-24
IT7822629A0 (it) 1978-04-21
GB1590668A (en) 1981-06-03
CA1113088A (fr) 1981-11-24
DK147918C (da) 1985-08-19

Similar Documents

Publication Publication Date Title
ES477265A1 (es) Procedimiento para la preparacion de fosfato y sales de me- tronidazol.
ES8608535A1 (es) Procedimiento para preparar una composicion para el tratamiento topico de acne
ES476919A1 (es) Procedimiento para la preparacion de nuevos compuestos de 2-pirrolidona.
FR2405926A1 (fr) (asn2)-thymosine a1 et procede de preparation
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
ES8506569A1 (es) Un procedimiento para la preparacion de nuevos indonaftoles.
FR2358141A1 (fr) Nouveaux anesthesiques locaux
KR830004219A (ko) 약리적 활성 펩티드
GB1500434A (en) Tertiary amines
ES449130A1 (es) Procedimiento para la preparacion de 2-hidroxibenzantrona y sus derivados de substitucion.
IE45222L (en) 2-loweralkyl-2- or -3-cephem-4-carboxylic acids.
FR2414497A1 (fr) Analogues de betah-endorphine et procede pour leur preparation
FR2392009A1 (fr) Monosulfate de 3-phenoxypyridine et procede pour sa preparation
GB1317206A (en) Propargyl esters and a process for the preparation thereof
ES8506598A1 (es) Un procedimiento para la preparacion del ester 1-metilico de la n-l -aspartil-l-fenilalanina (aspartamo)
ES8406507A1 (es) Procedimiento para la preparacion de hexanorbrassinolid-22-eteres
MY102760A (en) New surfactants.
GB2001990A (en) Preparation of 16 alpha -methyl- prednisolone and derivatives thereof via 17 alpha -hydroperoxy analogues
FR2375236A1 (fr) Analyse de thromboxane et son procede de preparation
NO170279C (no) Fremgangsmaate for fremstilling av piperidinylcyklopentylheptensyred erivater
ES8307252A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido clavulanico.
ES8205219A1 (es) Un metodo para producir un compuesto de hidrouracilo
ES471356A1 (es) Procedimiento de obtencion de r,s-2,3,5,6-tetrahidro-6-fenil-imidazo (2,1-b)-tiazole (tetramisole)
JPS57200391A (en) 1-(5-oxo-2-hexenyl)3,7-dimethylxanthine
JPS5427546A (en) Liquid crystal compound

Legal Events

Date Code Title Description
ST Notification of lapse